RCE recce pharmaceuticals ltd

Ann: R327 Efficacy against WHO Priority Pathogen Acinetobacter B, page-6

  1. rl
    87 Posts.
    lightbulb Created with Sketch. 13
    perhaps the value lies in the fact that the can safely inject R327 into a patient but they can't inject bleach, to kill these bacteria. As for their inablity to recruit patients... That seems worth noting. Was there any explanation as to why they weren't able to recruit more patients?

    Correct me if I'm wrong but I seem to recall seeing a number of photos of healed diabetic ulcers which had not responded to the conventional protocols....was this unrelated or irrelevant? Serious question... always appreciate being better informed.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
30.5¢
Change
-0.010(3.17%)
Mkt cap ! $87.95M
Open High Low Value Volume
31.0¢ 31.0¢ 30.0¢ $25.09K 82.18K

Buyers (Bids)

No. Vol. Price($)
6 32855 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.5¢ 16280 1
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.